$550 Includes medication, syringes, alcohol pads, and shipping
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Who GHK-Cu Is For and Who Should Avoid It GHK-Cu is most often discussed by adults exploring skin-quality, hair-quality, or tissue-repair research, especially in the context of age-related collagen decline
Gross necropsy and histopathologic examination of animals receiving high-dose BPC-157 found no organ damage in liver, spleen, lung, kidney, brain, thymus, prostate, ovaries, or gastric wall